Details of Epigenetic Molecule(EM)
General Information of EM (ID: EM12065) | |||||||
---|---|---|---|---|---|---|---|
Official Symbol |
FLCN
|
||||||
Official Full Name |
Folliculin
|
||||||
Synonym |
Folliculin;DENND8B;BHD;BHD Skin Lesion Fibrofolliculoma Protein;Birt-Hogg-Dube Syndrome Protein;MGC17998;MGC23445;FLCL
|
||||||
Molecule Type |
Protein coding
|
||||||
Position On Chromosome |
chr17(Start:17206946 - End:17237188)
|
||||||
Strand |
-
|
||||||
Uniprot Entry | |||||||
ENSG ID | |||||||
Disease Relevance (Click to Show/Hide) | |||||||
5A02: Thyrotoxicosis | Graves' disease [Thyrotoxicosis] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
8A00: Parkinsonism | Parkinson's disease (PD) [Parkinsonism] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
8A01: Choreiform disorders | Huntington's disease (HD) [Choreiform disorders] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
8A20: Alzheimer disease | Alzheimer's disease [Alzheimer disease] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
CB03: Idiopathic interstitial pneumonitis | Idiopathic pulmonary fibrosis (IPF) [Idiopathic interstitial pneumonitis] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
LD2B: Syndromes with premature ageing appearance as a major feature | Werner Syndrome [Syndromes with premature ageing appearance as a major feature] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
SE30: Developmental delay disorder | CHARGE and Kabuki syndromes [Developmental delay disorder] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
XH5QN3: Nephroblastoma | Wilms tumor [Nephroblastoma] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
ZERO(Not Found): Glomerular diseases | IgA nephropathy [Glomerular diseases] | ||||||
Detailed Information |
Disease Link
![]() |
Metabolite(s) with this epigenetic modification | |||||||
---|---|---|---|---|---|---|---|
Metabolite Name: Resveratrol | |||||||
Detailed Information |
Meta Info
![]() |
[1], [2] | |||||
Description |
Resveratrol could change tumor suppressor gene FLCN from hypermethylated to hypomethylated status in MDA-MB-231 breast cancer cells treated with resveratrol (100 M) at 48 h.
|
||||||
Metabolite Name: Valerate | |||||||
Detailed Information |
Meta Info
![]() |
[3], [1] | |||||
Description |
Valerate has been shown to hypermethylate FLCN CpG site in breast cancer cells.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.